MRNA
ModernaยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
MRNA Profile
Moderna, Inc.
A biotech company pioneering messenger RNA (mRNA) therapeutics and vaccines
Biological Technology
07/22/2016
12/07/2018
NASDAQ Stock Exchange
5,800
12-31
Common stock
325 Binney Street, Cambridge, Massachusetts 02142
Biopharmaceuticals in genetic engineering
Moderna, Inc., was incorporated under the laws of the State of Delaware on July 22, 2016. The company is a leader in the field of messenger ribonucleic acid (messenger ribonucleic acid) medicine. Through more than a decade of work at the intersection of science, technology and health, the company has developed drugs with unprecedented speed and efficiency, including one of the earliest and most effective Covid-19 vaccines. The company's mRNA platform has enabled the development of therapies and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by Moderna's values and mindset to responsibly change the future of human health, the company strives to deliver the greatest possible impact to people through mRNA medicines.
